Evaldo Stanislau Affonso de Araújo

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

Michael P. Manns, Patrick Marcellin, Fred Poordad et al. · The Lancet · 2014 · 375 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL

M.P. Manns, Patrick Marcellin, Fred Poordad et al. · Journal of Hepatology · 2013 · 122 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Use of an Immunoglobulin G Avidity Test To Discriminate between Primary and Secondary Dengue Virus Infections

Vanda Akico Ueda Fick de Souza, Evaldo Stanislau Affonso de Araújo, Adriana Fumie Tateno et al. · Journal of Clinical Microbiology · 2004 · 97 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Microbial Translocation Is Associated with Extensive Immune Activation in Dengue Virus Infected Patients with Severe Disease

Cornelia A. M. van de Weg, Cláudio Mendes Pannuti, Evaldo Stanislau Affonso de Araújo et al. · PLoS neglected tropical diseases · 2013 · 94 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Inter- and Intra-Host Viral Diversity in a Large Seasonal DENV2 Outbreak

Camila Malta Romano, Michael Lauck, Felipe Scassi Salvador et al. · PLoS ONE · 2013 · 73 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15